Replies to post #344450 on Anavex Life Sciences Corp (AVXL)

[Double-Trouble]

They will need cash for all the law suite.
TGD opened the door for it!

[Talon38]

The dementia/Alzhemer's world is in turmoil and much to the credit of the FDA and Biogen. AVXL will have keep its clinical lead although Wall Street is not much help. The Rett data....when it is released....will give us impetus until P2/3 Alzheimer's dada arrives later this year. This an endurance run!!!
----

https://www.investors.com/news/technology/dnli-stock-biogen-is-not-the-only-alzheimers-company-facing-bad-news/?src=A00220

[BIOChecker4]

Totally agree. We’ll know when the stock has hit bottom when the volume exceeds 1, 2 or even 3 million shares. With about $2 a share in cash, there’s a lot of downside risk. I don’t expect the stock to trade that low. I think the pipeline is worth about $4 a share, so I’d be a buyer at around $6.